Drugs of the Future

ISSN: 0377-8282

Journal Home

Journal Guideline

Drugs of the Future Q4 Unclaimed

Prous Science Spain
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drugs of the Future is an interdisciplinary biomedical research journal that publishes well-documented, peer-reviewed articles on topics emerging from the confluence of scientific fields including chemistry, biology, pharmacology, genomics and medicine. The journal identifies and anticipates new trends, advances and breakthroughs in basic, translational and clinical research, and includes the following sections: It has an SJR impact factor of 0,15.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Non Open Access

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

- €

Embargoed OA

0 €

Non OA

Metrics

Drugs of the Future

0,15

SJR Impact factor

46

H Index

7

Total Docs (Last Year)

262

Total Docs (3 years)

208

Total Refs

27

Total Cites (3 years)

261

Citable Docs (3 years)

0.09

Cites/Doc (2 years)

29.71

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Penbutolol

View more

Halopredone Diacetate

View more

X-linked hypophosphatemia: Understanding and management

View more

Memantine

View more

DBCO

View more

Proquazone

View more

L-10503

View more

LR 511

View more

LR 534

View more

Defactinib hydrochloride. Dual FAK1/PYK2 inhibitor, Treatment of non-small cell lung cancer, treatment of malignant mesothelioma, treatment of ovarian cancer

View more

Aliflurane

View more

Gemcadiol

View more
SHOW MORE ARTICLES

Alletorphine

View more

Morocromen

View more

Norgestimate

View more

D-32

View more

N-propylnoraporphine

View more

GYKI-13504

View more

Clazolimine

View more

Butibufen

View more

Cartazolate

View more

Gemfibrozil

View more

Cloprednol

View more

Tocainide

View more

FAQS